Sarepta Therapeutics has shared a community bulletin addressing questions about COVID-19 vaccination and gene therapy. This update confirms information presented during PPMD’s recent webinar, which will likely be consistent across all clinical trials. For more information on COVID-19 vaccination and Duchenne, please visit PPMD’s FAQ resource.

Read Sarepta’s Community Bulletin >